Short bowel syndrome (SBS) is a complex disease that occurs
due to the physical loss or the loss of function of a portion of the small
and/or large intestine. SBS is generally broken down into individuals in whom
the disorder is acquired during life and newborns in which the disorder is
present at birth (congenital).
Acquired short bowel syndrome is more common than the
congenital form of the disorder. The specific symptoms and severity of SBS vary
from one person to another. Diarrhea is common, often severe, and can cause
dehydration, which can even be life-threatening. SBS can lead to malnutrition,
unintended weight loss, and additional symptoms may be due to the loss of
essential vitamins and minerals. SBS is most commonly associated with surgical
removal (resection) of half or more of the small intestine.
View Short bowel syndrome Market
Such surgery is performed to treat intestinal diseases such
as Crohn's disease, injury or trauma to the small bowel, or congenital birth
defects. In some cases, newborns can be born with a shortened bowel that is
present at birth (congenital short bowel syndrome). The exact cause of short
bowel in these cases is not fully understood and several different theories
have been proposed.
More research is necessary to determine what factors
ultimately lead to congenital short bowel syndrome. The disease also increases
the chances of developing kidney stones, electrolyte abnormalities, vitamin and
mineral deficiencies, acidosis, and gastric hypersecretion.
The manifestations of intestinal resection and SBS are a
result of; the loss of intestinal absorption surface; the loss of specific
sites of absorption; a decrease in the production of intestinal hormones; and the
loss of the ileocecal valve.
Short bowel syndrome may be mild, moderate, or severe,
depending on how well the small intestine is working. It is considered a
rare disease, and it affects about three out of every million people. A
diagnosis of SBS is made based upon detailed patient history, a thorough
clinical evaluation, and a variety of specialized tests, including laboratory
tests and X-ray studies. It is also found that most of the cases are undiagnosed
in areas with a lack of intestinal rehabilitation centers and weak home PN/IV programs.
The treatment of SBS is directed toward the specific
symptoms that are apparent in each individual. It includes nutritional support,
medications, surgery, and intestinal transplant. The specific therapeutic
procedures and interventions for individuals with a short bowel syndrome might
vary, depending upon numerous factors, including the specific symptoms, the site, and extent of the affected portion of the small intestine, whether the colon is
involved, an individual’s age and overall health, tolerance of certain
medications or procedures, personal preference, and other factors.
In mild cases, slowly increasing the oral intake of food and taking certain supplements or medications for diarrhea may be all that is required. However, in many severe cases, TPN might be necessary, wherein short bowel syndrome may potentially require a small bowel transplant. In In recent years, advances in therapy, including new options like recombinant growth hormone and glucagon-like peptide analogs and improvements in surgical techniques have lessened the length of time that individuals need to remain on TPN.
Original Source:- Short bowel syndrome Market Report
Comments
Post a Comment